Michael A. Polis

12.8k citations

143 papers · 8.6k · 2 hit papers · h-index 43

Impact in

Virology top 0.05%
- HIV Research and Treatment
Infectious Diseases top 0.2%
- HIV/AIDS drug development and treatment
- HIV/AIDS Research and Interventions

Papers in

Epidemiology 57
- Cytomegalovirus and herpesvirus research 22
- Pneumocystis jirovecii pneumonia detection and treatment 15
- Hepatitis B Virus Studies 14
- Liver Disease Diagnosis and Treatment 10
Infectious Diseases 53
- HIV/AIDS drug development and treatment 35
- HIV/AIDS Research and Interventions 23

Co-authors: Richard T. Davey (44 shared papers)Henry Masur (67 shared papers)Joseph A. Kovacs (44 shared papers)Julia A. Metcalf (26 shared papers)Judith Falloon (34 shared papers)H. Clifford Lane (30 shared papers)Robert Walker (22 shared papers)Robin Dewar (16 shared papers)
Journals: The Journal of Infectious Diseases (16 papers)AIDS (15 papers)Antimicrobial Agents and Chemotherapy (8 papers)AIDS Research and Human Retroviruses (7 papers)Journal of Medical Virology (5 papers)
Partner nations: United States Germany Mali

In The Last Decade

Michael A. Polis

140 papers receiving 8.4k citations

Michael A. Polis's Hit Papers

align trajectories log scale

HIV-1 and T cell dynamics after interruption of highly active antiretroviral therapy (HAART) in patients with a history of sustained viral suppression 1999 · 642 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

1999 Proceedings of the National Academy of Sciences
1998 Nature

Peers

Countries citing papers authored by Michael A. Polis

Since Specialization

Citations

This map shows the geographic impact of Michael A. Polis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael A. Polis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael A. Polis more than expected).

Fields of papers citing papers by Michael A. Polis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael A. Polis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael A. Polis. The network helps show where Michael A. Polis may publish in the future.

Co-authors

The 25 scholars most cited alongside Michael A. Polis, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michael A. Polis Line = papers co-authored together Michael A. Polis links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 143 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Changes in thymic function with age and during the treatment of HIV infection Nature ·Daniel C. Douek, Richard McFarland, Philip Keiser, Earl A. Gage, Janice M. Massey, Barton F. Haynes, Michael A. Polis, Ashley T. Haase, Mark B. Feinberg, John L. Sullivan, Beth D. Jamieson, Jerome A. Zack, Louis J. Picker, Richard A. Koup Hit paper breakdown →	1998	1495
2	HIV-1 and T cell dynamics after interruption of highly active antiretroviral therapy (HAART) in patients with a history of sustained viral suppression Proceedings of the National Academy of Sciences ·Richard T. Davey, Niranjan Bhat, Christian Yoder, Tae‐Wook Chun, Julia A. Metcalf, Robin Dewar, Ven Natarajan, Richard A. Lempicki, Joseph W. Adelsberger, Kirk D. Miller, Joseph A. Kovacs, Michael A. Polis, Robert Walker, Judith Falloon, Henry Masur, Dennis Gee, Michael Baseler, Dimiter S. Dimitrov, Anthony S. Fauci, H. Clifford Lane Hit paper breakdown →	1999	642
3	New Real-Time Reverse Transcriptase-Initiated PCR Assay with Single-Copy Sensitivity for Human Immunodeficiency Virus Type 1 RNA in Plasma Journal of Clinical Microbiology ·Sarah Palmer, Ann Wiegand, Frank Maldarelli, Holly Bazmi, JoAnn M. Mican, Michael A. Polis, Robin Dewar, Angeline Planta, Shuying Liu, Julia A. Metcalf, John W. Mellors, John M. Coffin	2003	474
4	Increases in CD4 T Lymphocytes with Intermittent Courses of Interleukin-2 in Patients with Human Immunodeficiency Virus Infection — A Preliminary Study New England Journal of Medicine ·Joseph A. Kovacs, Michael Baseler, Robin Dewar, Susan Vogel, Richard T. Davey, Judith Falloon, Michael A. Polis, Robert Walker, Randy Stevens, Norman P. Salzman, Julia A. Metcalf, Henry Masur, H. Clifford Lane	1995	336
5	Controlled Trial of Interleukin-2 Infusions in Patients Infected with the Human Immunodeficiency Virus New England Journal of Medicine ·Joseph A. Kovacs, Susan Vogel, Jeffrey M. Albert, Judith Falloon, Richard T. Davey, Robert Walker, Michael A. Polis, Katherine Spooner, Julia A. Metcalf, Michael Baseler, G. Fyfe, H. C. Lane, Robin Dewar, Henry Masur	1996	321
6	ART Suppresses Plasma HIV-1 RNA to a Stable Set Point Predicted by Pretherapy Viremia PLoS Pathogens ·Frank Maldarelli, Sarah Palmer, Martin King, Ann Wiegand, Michael A. Polis, JoAnn M. Mican, Joseph A. Kovacs, Richard T. Davey, Diane Rock-Kress, Robin Dewar, Shuying Liu, Julia A. Metcalf, Catherine Rehm, Scott C. Brun, George J. Hanna, Dale J. Kempf, John M. Coffin, John W. Mellors	2007	267
7	A Randomized, Controlled Trial of Foscarnet in the Treatment of Cytomegalovirus Retinitis in Patients with AIDS Annals of Internal Medicine ·Alan G. Palestine, Michael A. Polis, Marc D. de Smet, Barbara Baird, Judith Falloon, Joseph A. Kovacs, Richard T. Davey, John Zurlo, Kathryn M. Zunich, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	1991	240
8	Identification of Dynamically Distinct Subpopulations of T Lymphocytes That Are Differentially Affected by HIV The Journal of Experimental Medicine ·Joseph A. Kovacs, Richard A. Lempicki, Igor A. Sidorov, Joseph W. Adelsberger, Betsey Herpin, Julia A. Metcalf, Irini Sereti, Michael A. Polis, Richard T. Davey, Jorge A. Tavel, Judith Falloon, Randy Stevens, Laurie Lambert, Robin Dewar, Douglas J. Schwartzentruber, Miriam R. Anver, Michael Baseler, Henry Masur, Dimiter S. Dimitrov, H. Clifford Lane	2001	181
9	Impact of HIV-1 infection and highly active antiretroviral therapy on the kinetics of CD4 ⁺ and CD8 ⁺ T cell turnover in HIV-infected patients Proceedings of the National Academy of Sciences ·Richard A. Lempicki, Joseph A. Kovacs, Michael Baseler, Joseph W. Adelsberger, Robin Dewar, Ven Natarajan, Marjorie Bosche, Julia A. Metcalf, Randy Stevens, Laurie Lambert, W. Gregory Alvord, Michael A. Polis, Richard T. Davey, Dimiter S. Dimitrov, H. Clifford Lane	2000	159
10	Endogenous intrahepatic IFNs and association with IFN-free HCV treatment outcome Journal of Clinical Investigation ·Eric G. Meissner, David Wu, Anu Osinusi, Dimitra Bon, Kimmo Virtaneva, Dan E. Sturdevant, Steve Porcella, Honghui Wang, Eva Herrmann, John G. McHutchison, Anthony F. Suffredini, Michael A. Polis, Stephen M. Hewitt, Ludmila Prokunina‐Olsson, Henry Masur, Anthony S. Fauci, Shyamasundaran Kottilil	2014	155
11	Idiopathic CD4+ lymphocytopenia: natural history and prognostic factors Blood ·Dimitrios Zonios, Judith Falloon, John E. Bennett, Pamela A. Shaw, Doreen Chaitt, Michael Baseler, Joseph W. Adelsberger, Julia A. Metcalf, Michael A. Polis, Stephen J. Kovacs, Joseph A. Kovacs, Richard T. Davey, H. Clifford Lane, Henry Masur, Irini Sereti	2008	154
12	Clinical pharmacokinetics of cidofovir in human immunodeficiency virus-infected patients Antimicrobial Agents and Chemotherapy ·K C Cundy, Brent G. Petty, John F. Flaherty, Pearl Fisher, Michael A. Polis, M. Wachsman, Paul S. Lietman, Jacob Lalezari, Michael J. M. Hitchcock, Howard S. Jaffe	1995	143
13	Subcutaneous Administration of Interleukin‐2 in Human Immunodeficiency Virus Type 1—Infected Persons The Journal of Infectious Diseases ·Richard T. Davey, Doreen Chaitt, Stephen C. Piscitelli, Mary Wells, Joseph A. Kovacs, Robert Walker, Judith Falloon, Michael A. Polis, Julia A. Metcalf, Henry Masur, G. Fyfe, H. Clifford Lane	1997	140
14	Occurrence, Predictors, and Consequences of Adult Asthma in NHANESI and Follow-up Survey American Review of Respiratory Disease ·William P. McWhorter, Michael A. Polis, Richard A. Kaslow	1989	129
15	High Prevalence of Osteonecrosis of the Femoral Head in HIV-Infected Adults Annals of Internal Medicine ·(unknown), Henry Masur, Elizabeth C. Jones, (unknown), Margaret E. Rick, (unknown), JoAnn M. Mican, (unknown), Lynn H. Gerber, William C. Blackwelder, Judith Falloon, Richard T. Davey, Michael A. Polis, Robert Walker, H. Clifford Lane, Joseph A. Kovacs	2002	128
16	Ongoing HIV dissemination during HAART Nature Medicine ·Zvi Grossman, Michael A. Polis, Mark B. Feinberg, Zehava Grossman, I Levi, Shirley Jankelevich, Robert Yarchoan, Jacob Boon, Frank de Wolf, Joep M.A. Lange, Jaap Goudsmit, Dimiter S. Dimitrov, William E. Paul	1999	125
17	Loss of Human Immunodeficiency Virus Type 1 (HIV-I) Antibodies with Evidence of Viral Infection in Asymptomatic Homosexual Men Annals of Internal Medicine ·Homayoon Farzadegan, Michael A. Polis, Steven M. Wolinsky, Charles R. Rinaldo, JJ Sninsky, S Kwok, Robert L. Griffith, Richard A. Kaslow, John Phair, B. Frank Polk, (unknown)	1988	123
18	Ledipasvir and sofosbuvir for hepatitis C genotype 4: a proof-of-concept, single-centre, open-label phase 2a cohort study The Lancet Infectious Diseases ·Anita Kohli, Rama Kapoor, Zayani Sims, Amy Nelson, Sreetha Sidharthan, Brian Lam, Rachel Silk, Colleen Kotb, Chloe Gross, Gebeyehu Teferi, Kate Sugarman, Phillip S. Pang, Anu Osinusi, Michael A. Polis, Vinod K. Rustgi, Henry Masur, Shyam Kottilil	2015	117
19	A Randomized Trial of High‐ versus Low‐Dose Subcutaneous Interleukin‐2 Outpatient Therapy for Early Human Immunodeficiency Virus Type 1 Infection The Journal of Infectious Diseases ·Richard T. Davey, Doreen Chaitt, Jeffrey M. Albert, Stephen C. Piscitelli, Joseph A. Kovacs, Robert Walker, Judith Falloon, Michael A. Polis, Julia A. Metcalf, Henry Masur, Robin Dewar, Michael Baseler, G. Fyfe, Martin Giedlin, H. Clifford Lane	1999	113
20	Drug Interactions in Patients Infected with Human Immunodeficiency Virus Clinical Infectious Diseases ·Stephen C. Piscitelli, Charles Flexner, J R Minor, Michael A. Polis, Henry Masur	1996	103

About Michael A. Polis

Michael A. Polis is a scholar working on Epidemiology, Infectious Diseases, Virology, Hepatology and Immunology, having authored 143 papers that have together received 8.6k indexed citations. Recurring topics across this work include HIV Research and Treatment (45 papers), Hepatitis C virus research (41 papers), HIV/AIDS drug development and treatment (35 papers), HIV/AIDS Research and Interventions (23 papers), Cytomegalovirus and herpesvirus research (22 papers), Pneumocystis jirovecii pneumonia detection and treatment (15 papers), Hepatitis B Virus Studies (14 papers) and Liver Disease Diagnosis and Treatment (10 papers). The work is most often cited by research in Virology (3.9k citations), Infectious Diseases (2.7k citations), Immunology (2.5k citations), Hepatology (834 citations) and Epidemiology (2.4k citations). Michael A. Polis has collaborated with scholars based in United States, Germany and Mali. Frequent co-authors include Richard T. Davey, Henry Masur, Joseph A. Kovacs, Julia A. Metcalf, Judith Falloon, H. Clifford Lane, Robert Walker, Robin Dewar, Mark B. Feinberg and Michael Baseler. Their work appears in journals such as The Journal of Infectious Diseases, AIDS, Antimicrobial Agents and Chemotherapy, AIDS Research and Human Retroviruses and Journal of Medical Virology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Michael A. Polis

Impact in

Papers in i

In The Last Decade

Michael A. Polis

Michael A. Polis's Hit Papers

Peers

Countries citing papers authored by Michael A. Polis

Fields of papers citing papers by Michael A. Polis

All Works

About Michael A. Polis

Explore authors with similar magnitude of impact

Papers in